{
  "actions": [
    {
      "acted_at": "2021-02-08",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-02-08",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s298-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "B001310",
      "district": null,
      "name": "Braun, Mike",
      "original_cosponsor": true,
      "sponsored_at": "2021-02-08",
      "state": "IN",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-02-08",
  "number": "298",
  "official_title": "A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr1829-117",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    },
    {
      "bill_id": "s4293-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Pharmacy Benefit Manager Accountability Study Act of 2021",
  "sponsor": {
    "bioguide_id": "B001243",
    "district": null,
    "name": "Blackburn, Marsha",
    "state": "TN",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-02-08",
  "subjects": [
    "Congressional oversight",
    "Drug therapy",
    "Government employee pay, benefits, personnel management",
    "Government studies and investigations",
    "Health",
    "Health care costs and insurance",
    "Inflation and prices",
    "Medicaid",
    "Medicare",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-02-08",
    "date": "2021-04-01T14:13:29Z",
    "text": "Pharmacy Benefit Manager Accountability Study Act of 2021\n\nThis bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Pharmacy Benefit Manager Accountability Study Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Pharmacy Benefit Manager Accountability Study Act of 2021",
      "type": "short"
    }
  ],
  "updated_at": "2023-03-08T20:12:49Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s298.xml"
}